Covid-19: Countries striking vaccine deals with firms could crowd out other developers

By: |
Published: June 16, 2020 4:30 AM

Countries striking vaccine deals with companies could crowd out other vaccine developers.

These large deals will, no doubt, push vaccine research (with the aim to make an effective and safe vaccine available at the earliest) and access.These large deals will, no doubt, push vaccine research (with the aim to make an effective and safe vaccine available at the earliest) and access.

Pharma behemoth Astra Zeneca has struck a deal with the Inclusive Vaccine Alliance—an alliance between Germany, Italy, France and the Netherlands to speed up the production of a vaccine against SARS-CoV-2—to supply 400 million doses of a vaccine being tested by the University of Oxford. This is the latest of a series of such deals that the company has struck—one with the UK for 30 million doses, a $1.2 billion deal with the US for 300 million doses, and another with the Global Alliance for Vaccines and Immunizations (Gavi) for 700 million doses.

These large deals will, no doubt, push vaccine research (with the aim to make an effective and safe vaccine available at the earliest) and access. And access is crucial, given, in the absence of pharmacological interventions, countries have had to rely on lockdowns that come at serious economic costs.

However, with vaccine research happening across nations, with multiple companies in the fray, such deals effectively mean other vaccine developers are forced out of vaccine research (because finding flows to one company), or if they survive that, out of the market.

To be sure, it is imperative to roll out countrywide vaccination programmes in the current context, and a deal with a vaccine developer makes eminent sense. But, it is akin to putting all your eggs in one basket—what if another developer has a better vaccine?

Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Financial Express is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.

Next Stories
1Agri revolution 2.0: New ordinance set to revolutionise agriculture, but Centre needs state co-operation
2Cropping success: Why farmers don’t want to furnish land information to sell their products on online portals
3Why there’s a need to stabilise the GST tech platform